Alcon. has filed a patent for a system that allows for the removable attachment of a drive mechanism handpiece to an intraocular lens (IOL) cartridge. The cartridge includes a retractable cap that exposes the nozzle and folds the IOL upon retraction. This innovation aims to improve the delivery of IOLs during eye surgeries. GlobalData’s report on Alcon gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Alcon, Prosthetic cardiac valves was a key innovation area identified from patents. Alcon's grant share as of January 2024 was 52%. Grant share is based on the ratio of number of grants to total number of patents.
Iol cartridge with retractable cap for lens manipulation
See Also:
The patent application (Publication Number: US20240033074A1) describes an innovative intraocular lens (IOL) cartridge designed for the delivery of IOLs into the eye during surgical procedures. The cartridge comprises a unique design with a compartment for holding the IOL, a retractable cap, and a plunger case in fluid communication with the compartment. The retractable cap can be manipulated from a first position to a second position to expose the nozzle and facilitate the delivery of the IOL. Additionally, the cartridge includes features such as edge rollers and compression arms that aid in folding and compressing the IOL for efficient delivery.
Furthermore, the patent application details a method for the delivery of an IOL into the eye using the described IOL cartridge. The method involves attaching the cartridge to a handpiece, retracting the retractable cap to expose the nozzle and fold the IOL, and then actuating the handpiece to deliver the IOL from the compartment through the nozzle. This method streamlines the process of IOL delivery during eye surgeries, providing a more efficient and controlled mechanism for surgeons. Overall, the innovative design of the IOL cartridge and the accompanying delivery method outlined in the patent application aim to enhance the precision and effectiveness of IOL implantation procedures, ultimately benefiting patients undergoing cataract surgery or other eye-related interventions.
To know more about GlobalData’s detailed insights on Alcon, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
